🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…CLAIM SALE

U.S. futures steady amid E.Z. worries; Dow Jones up 0.06%

Published 03/19/2013, 07:49 AM
Updated 03/19/2013, 07:50 AM
NDX
-
UK100
-
FCHI
-
DJI
-
DE40
-
STOXX50
-
JP225
-
HK50
-
BA
-
C
-
VLO
-
NWSA
-
AFFY
-

Investing.com - U.S. stock futures pointed to a steady open on Tuesday, as markets were jittery amid sustained concerns over the handling of the sovereign debt crisis in the euro zone.

Ahead of the open, the Dow Jones Industrial Average futures pointed to a 0.06% gain, S&P 500 futures signaled a 0.10% rise, while the Nasdaq 100 futures indicated a 0.11% increase.

Sentiment weakened on Monday following news that a one-time tax was to be imposed on bank deposit holders as part of a EUR10 billion bailout deal for Cyprus.

The agreement marked the first time since the onset of the euro zone debt crisis that depositors have been forced to take a haircut in return for financial aid.

Meanwhile, investors were looking ahead to the outcome of the Federal Reserve’s policy meeting on Wednesday after data on Friday showing that U.S. inflation was contained in February left the way clear for the bank to continue its asset purchase program.

Financial stocks were expected to be active, after Citigroup said it agreed to pay USD730 million to settle a class action lawsuit on behalf of investors who said they were misled by the lender's disclosures.

Separately, BlackRock, the world's largest money manager, was reportedly preparing to cut nearly 300 jobs, or about 3% of its workforce.

Aircraft manufacturers Boeing was also likely to remain in focus, technical workers voted to ratify a new four-year labor agreement with the company, ending the possibility of a strike that could have cut production.

Among pharmaceuticals, drugmaker Affymax was slated to move lower, following a more than 57% drop on Monday, after it said it was considering selling itself or filing for bankruptcy, as it struggles to stay afloat following the recent recall of its sole commercial product, the anemia drug Omontys.

Elsewhere, the head of Valero Energy said on Monday his company is not pursuing a sale of its two California refineries, putting an end to months of speculation.

Across the Atlantic, European stock markets were lower. The EURO STOXX 50 slid 0.71%, France’s CAC 40 tumbled 0.91%, Germany's DAX declined 0.52%, while Britain's FTSE 100 declined 0.31%.

During the Asian trading session, Hong Kong's Hang Seng Index slipped 0.19%, while Japan’s Nikkei 225 Index surged 2.03%.

Later in the day, the U.S. was to release official data on building permits and housing starts.


Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.